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Malignant distal biliary obstruction (MDBO) is a
frequent complication of pancreaticobiliary and
metastatic malignancy. Endoscopic retrograde
cholangiopancreatography (ERCP) is the current
gold standard for decompressing the biliary tree
in this population [1–4]. However, ERCP can be
unsuccessful in 5% to 10% of patients with MDBO
due to tumor-related alterations in the periam-
pullary anatomy, as well as physician and patient
factors [1]. Traditionally, unsuccessful ERCP has
been followed by percutaneous biliary drainage
(PBD) or surgical intervention to obtain biliary
decompression [1]. PBD is a well-established and
effective method for biliary decompression in the
setting of malignant obstruction. However, in
most cases, at least temporary external drainage
and repeated interventions for drainmaintenance
are often required following PBD; leading to po-
tential treatment interruptions and lower quality
of life [5]. Over the past decade, advances in tech-
nology and development of new techniques have
allowed endoscopic ultrasound guided biliary
drainage (EUS-BD) to be used as an alternative in
patients with MDBO.
Various techniques of EUS-BD have been de-
scribed, including EUS-guided choledochoduode-
nostomy, EUS-guided rendezvous (EUSr), and
EUS-guided antegrade stent placement. Early
data have demonstrated that in expert hands,
EUS-BD is superior to PBD in regards to success
of internal biliary drainage and complications
and may overall improve a patient’s quality of
life [4]. The overall technical and clinical success
rates of EUS-BD is approximately 80%with a com-
plication rate of approximately 10% [6]. Only a
few studies have attempted to compare the safety
and efficacy of EUS-BD to PBD. In the most recent
report, Khashab et al. found that EUS-BD was a
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Background and study Aims: Selective biliary can-
nulation is unsuccessful in 5% to 10% of patients
undergoing endoscopic retrograde cholangiopan-
creatography (ERCP) for malignant distal biliary
obstruction (MDBO). Percutaneous biliary drain-
age (PBD) has been the gold standard, but endo-
scopic ultrasound guided rendezvous (EUSr)
have been increasingly used for biliary decom-
pression in this patient population. Our aim was
to compare the initial success rate, long-term effi-
cacy, and safety of PBD and EUSr in relieving
MDBO after failed ERC
Patients and methods: A retrospective study in-
volving 50 consecutive patients who had an initial
failed ERCP for MDBO. Twenty-five patients un-
dergoing EUSr between 2008–2014 were com-
pared to 25 patients who underwent PBD imme-
diately prior to the introduction of EUSr at our
center (2002–2008). Comparisons were made
between the two groups with regard to technical
success, duration of hospital stay and adverse
event rates after biliary decompression.
Results: The mean age at presentation was 66.5
(±12.6 years), 28 patients (54.9%) were female.
The etiology of MDBO was pancreaticobiliary
malignancy in 44 (88%) and metastatic disease
in 6 (12%) cases. Biliary drainage was technically
successful by EUSr in 19 (76%) cases and by PBD
in 25 (100%) (P=0.002). Median length of hospi-
tal stay after initial drainage was 1 day in the
EUSr group vs 5 days in PBD group (P=0.02). Re-
peat biliary intervention was required for 4 pa-
tients in the EUSr group and 15 in the PBD group
(P=0.001).
Conclusions: Initial technical success with EUSr
was significantly lower than with PBD, however
when EUSr was successful, patients had a signifi-
cantly shorter post-procedure hospital stay and
required fewer follow-up biliary interventions.
Meeting presentations: Annual Digestive Dis-
eases Week 2015
safer and potentially more efficacious alternative to PBD [2].
However, in this study a variety of EUS-BD methods were em-
ployed and PBD was only performed after a failed attempt at
EUS-BD.
Because EUS-BD techniques and their role in treating MDBO are
still evolving, it remains unclear how outcomes compare to the
current gold standard in this setting, PBD. The aim of this study
was to compare the initial success rate, long- term efficacy and
safety of PBD and EUSr in relieving MDBO after failed initial ERC
Patients and Methods
!
This was a retrospective comparative study involving 50 conse-
cutive patients withMDBO inwhom biliary decompression could
not be achieved via ERCP at a single academic tertiary referral
center. Patients were identified from amanual search of the insti-
tutional endoscopic database (Provation MD, Minneapolis, MN).
A manual chart review was performed and the clinical and endo-
scopic datawere extracted from each patient’s electronic medical
record including demographics (age, gender), type of malignancy
(pancreaticobiliary, metastatic), laboratory data, complications,
number of repeat biliary interventions, and length of hospitaliza-
tion. Twenty-five consecutive patients who underwent EUSr be-
tween 2008 and 2014 were compared to a cohort of 25 patients
who underwent PBD immediately prior to the introduction of
EUSr at our center (2002–2008). All EUSr procedures performed
at our institution between 2008 and 2014 were included in this
study. Patients with surgically altered anatomy (Roux-En-Y gas-
tric bypass, pancreaticoduodenectomy, hepaticojejunostomy)
were excluded from the study. The Institutional Review Board of
Washington University School of Medicine/Barnes Jewish Hospi-
tal approved review of clinical data for the purpose of this study.
EUSr was performed at the university hospital endoscopy unit by
1 of 5 experienced endoscopists expert in EUS, ERCP, and inter-
ventional EUS.All patients were under monitored anesthesia
care and received antibiotics during the procedure and for 3 to 5
days thereafter. The number of failed ERCP attempts prior to at-
tempting EUSr or PBD was recorded. The definition of failed bili-
ary cannulation with ERCP was not standardized in this study
and the decision to use an alternative method of biliary cannula-
tion was determined by the attending endoscopist.
During the time of the study, our group’s approach to EUS-BD
was to attempt EUSr rather than other techniques after failed
ERC All EUSr were performed using a trans-duodenal approach
with the echoendoscope seated in the duodenal bulb. Primarily
this decision is based on the risk of complications, primarily bile
leak, with other EUS-BD methods. After failed ERCP at our center,
EUSr was attempted during the same endoscopy session. If EUSr
was unsuccessful, the decision to use an alternative method of
EUS-BD, refer a patient to PBD, or perform ERCP at a later date
was at the discretion of the attending endoscopist. All EUSr pro-
cedures were performed using a therapeutic linear echoendo-
scope (GF-UC140P or GF-UCT140; Olympus Medical Systems,
Center Valley, PA). Once the scope was seated in the duodenal
bulb, the bile duct was identified and color flow Doppler was
used to confirm the lack of intervening vessels. Next, the bile
duct was accessed, prior to 2009, using a 19-gauge FNA needle
and then using an access needle (EchoTip Access Needle, Cook
Medical Inc., Bloomington, IN) thereafter. The needle was ad-
vanced into the lumen of the extrahepatic bile duct, the stylet
was removed, and bile was aspirated to verify positioning within
the bile duct. Next, contrast was injected and a cholangiogram
was obtained. Following the cholangiogram, a long guidewire
[0.035 inch Jagwire (Boston Scientific Corporation, Natick, MA)
or 0.025 inch angled Visiglide wire (Olympus America, Center
Valley, PA)] was then passed through the access needle into the
bile duct. The guidewire was manually manipulated to advance
through the major papilla and was coiled within the duodenum.
The access needle and echoendoscope were then removed, leav-
ing the wire in place. Alongside the wire, a duodenoscope (TJF
140–160; Olympus Medical Systems, Center Valley, PA) was in-
serted to the level of the papilla. The biliary tree was then deeply
cannulated with a sphinctertome using the guidewire placed via
EUSr as a guide to where the biliary opening lay. If cannulation
was unsuccessful using this technique, then the luminal end of
the guidewire was grasped with a snare or forceps and pulled
through the duodenoscope so that both ends of the guidewire ex-
ited the patient’s mouth and were under the control of the
endoscopist. This allowed a sphinctertome or balloon catheter
to be advanced over the wire directly into the biliary tree. Subse-
quently, a biliary stent was placed across the stricture. Technical
success of EUSr was defined by the wire being advanced into the
duodenum via the major papilla and a stent placed in a retro-
grade manner (●" Fig.1). Patients were not routinely admitted to
the hospital for observation following EUSr if the procedure was
performed on an outpatient basis.
PBDwas performed by experts in Interventional Radiology under
moderate sedation using well established techniques [7]. Most
patients initially received external biliary drainage which at the
discretion of the attending radiologist could be converted to a
metallic biliary stent when clinically appropriate [7]. Patients
were monitored in the hospital for a minimum of 23 hours fol-
lowing PBD placement. Following PBD placement, any repeated
procedure (stent/tube exchange) was recorded as repeated inter-
ventions.
Procedure-related adverse events (AEs) were divided into early
(within 7 days) and late (greater than 7 days) from the index pro-
cedure. AE recorded included recurrent biliary obstruction,
bleeding (defined as an acute>3g/dL drop in Hgb requiring
PRBC transfusion or overt bleeding outside of what is typically
accepted post procedure that required further medical/surgical
management) , pancreatitis, bile leak and cholecystitis.
Statistical analysis
Data are reported as mean ± standard deviation (SD) for normally
distributed data, andmedian and range for skewed data. Grouped
continuous variable data were compared using two-tailed Stu-
dent’s t test and Mann-Whitney U test where appropriate. Inter-
group and categorical comparisons were made using the Chi-
square and Fisher’s exact tests. A p value of<0.05 was required
for statistical significance. All statistical analyses were performed
using PASW 19.1 (SPSS, Inc., Chicago, IL).
Results
!
During the 12-year study period, 1076 patients underwent an in-
itial ERCP for malignant distal biliary obstruction at our medical
center, biliary access via ERCP was unsuccessful in 54 (5.0%). Four
patients elected to pursue hospice care after failed ERCP, and fur-
ther attempts at biliary decompression were not made. Fifty pa-
tients [mean age 66.5 ±12.6 years, 28 (54.9%) females] were in-
cluded in this study. The etiology of MDBO was pancreaticobili-
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arymalignancy in 44 (88%) andmetastatic malignancy in 6 (12%)
cases. In the EUSr group, pancreaticobiliary malignancies includ-
ed pancreatic adenocarcinoma in 20 (80%), neuroendocrine tu-
mor in 1 (4%), and ampullary/duodenal cancer in 3 (12%) pa-
tients. Patients underwent a median of 1 (range 1–3) unsuccess-
ful ERCP attempts. The reason for failed biliary cannulation at
time of ERCP was tumor-related ampullary deformity in 34 (68
%) cases and inability to cannulate a normal appearing ampulla
in 16 (32%). There were no significant differences in any of the
baseline characteristics between the EUSr and PBD groups (●" Ta-
ble1).
Biliary drainage was technically successful by EUSr in 19 (76%)
cases and by PBD in 25 (100%) (P=0.002, ●" Table2). Median
length of hospital stay after initial drainage was 1 day (range 0–
26) in the EUSr group vs 5 days (range 1–20 days) in the PBD
group (P=0.02). Themedian length of hospital stay following suc-
cessful EUSr was 1 day (range 0–13), significantly shorter than
the PBD group (P= .002). Nine patients in the EUSr group under-
went the procedure on an outpatient basis and were not ad-
mitted to the hospital within the subsequent 14 days. Clinical
success, defined as a 50% drop in bilirubin within 7 days of the
index procedure was obtained in 24 (96%) in the EUSr group
and 20 (80%) of those in the PTC grou Five patients in the EUSr
and 5 patients in the PBD group underwent a pancreaticoduode-
nectomy at a median of 12 days (range 7–165) following biliary
drainage; there were no intraoperative of postoperative biliary
complications.
EUSr was unsuccessful in 6 cases (24%); summarized in●" Table3.
Reasons for failed EUSr included inability to pass the guidewire
antegrade into duodenum (n=5), inability to locate a safe win-
dow EUS for biliary puncture due to duodenal deformity (n=1).
In cases where EUSr was unsuccessful, biliary drainage was ob-
tained by PBD (n=3), repeat ERCP (n=2), and EUS-guided chole-
dochoduodenostomy (n=1). Both patients who had biliary access
obtained through repeat ERCP underwent the procedure within
24 hours after EUSr was attempted. The median time to PBD fol-
lowing failed ERCP was 1 (range 0–3) day. The median hospital
length of stay for failed EUSr was 4 days (range 0–26), which
was similar to the primary PBD group (5 days, P=0.64).






Age (years; mean± SD) 65.4 ± 11.6 67.7 ± 13.6 0.25
Gender (female) 15 13 0.57
Etiology of biliary obstruction
Pancreatobiliary malignancy 24 20 0.12
Metastatic malignancy 1 5
Unsuccessful ERCP attempts
(median, range)
1 (1–3) 1 (1–2) 0.26
Reason for failed ERCP
Tumor invasion/ deformity 18 7 0.54
Normal ampulla 16 9
Fig.1 EUS-guided rendezvous in an 84-year-old patient with obstructive jaundice due to an ampullary cancer. a Endoscopic examination revealed a large
mass, which made identification of the biliary orifice impossible. b Endosonographic examination revealed marked biliary ductal dilation and due to direct
extension of the tumor into the bile duct lumen. c Under endosonographic guidance the bile duct was punctured and a cholangiogram was obtained,
confirming findings observed on EUS examination. d,e Next, a guide wire was advanced into the duodenum and via the EUS needle. f Finally a covered metal
biliary stent was placed in a retrograde manner.
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Early AEs occurred in 4 (16%) patients in the EUSr group and 3
(12%) in the PBD groups (P=0.68,●" Table3). Early AEs included
recurrent biliary obstruction (2 PBD), bleeding (2 EUSr, 1 PBD),
pancreatitis (1 EUSr), and bile leak (1 EUSr). In the EUSr group,
bleeding was related to a gastroduodenal artery pseudoaneur-
ysm in 1 patient and was successfully treated with percutaneous
embolization; a second patient developed hemobilia from a PBD
after a failed EUSr, this was successfully treated by re-positioning
of the PBD. In the PBD group one patient developed hemobilia;
this was successfully treated with PBD repositioning and did not
require vascular intervention. Delayed AE occurred in 3 (12%) pa-
tients in the EUSr group and 6 (5%) in the PBD group (P=0.27)
(●" Table4).
Repeat biliary intervention was required for 3 patients in the
EUSr group and 14 in the PBD group (P=0.001). Scheduled biliary
interventions, including drain and stent changes were required
in 14 patients in the PBD group, a median of 19 days (range 1–
33) following initial drainage and in 3 patients in the EUSr group,
a median of 5 days (range 1–105) later (P<0.001). Conversion of
PBD to metal biliary stent was successful in 10 (40%) patients fol-
lowing initial PBD placement. Recurrent biliary obstruction, re-
quiring intervention occurred in 4 patients in the PBD group, at
a median of 237 days (range 1–272) after initial drainage and in
one patient in the EUSr group, 476 days after stent placement
(●" Fig.2, Log Rank P=0.01).
Discussion
!
Since being first reported in 2001 by Giovannini et al., EUS-BD
has been increasingly used as an alternative in patients with
MDBO who fail ERCP [8]. Numerous techniques have been and
are being developed with growing data supporting its use and ef-
ficacy [1–5,9–14]. In our study, EUSr was found to be a safe and
effective method of biliary drainage in patients with MDBO after
failed initial ERC It was associated with shorter post-procedure
Table 2 Post-procedure, per protocol analysis.
EUSr (n=25) PBD (n=25) P value
Initial technical success 19 25 0.009
Clinical success (reduction in bilirubin > 50% 24/25 (96%) 20/25 (80%)
Mean pre-EUS-BD bilirubin 10.85 13.24
Mean post-EUS-BD bilirubin 1.89 3.13
Length of hospital stay following initial drainage (median, range) 1 day (0 –26) 5 days (1–20) 0.022
Follow-up duration after initial drainage (median, range) 37 days (5–476) 11 (1–272) 0.013
Repeat procedure 3 15 0.001
Number repeat procedures (median, range) 0 (0–1) 1 (0–10) 0.001
Table 3 Patients who failed EUSr.




































ERCP 4 days Yes None yes




EUS-BD 26 days * yes None no




PBD 2 days yes None no




ERCP 0 days Yes None no




PBD 7 days Yes None no
EUSr, endoscopic ultrasound-guided rendezvous
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hospital stay and required fewer follow-up biliary interventions
than PBD.
Three techniques have been developed including EUS-guided
antegrade transluminal drainage (stenting using a transgastric
or transduodenal approach without accessing the papilla), EUS-
guided antegrade transpapillary stent placement, and EUSr.
From a large analysis of EUS-guided biliary techniques, the over-
all success rate of EUSr is estimated to be 81% with a complica-
tion rate about 10% of cases [6]. We recognize that there has
been a more recent push for utilizing a protocol based approach
to different rendezvous techniques, with some endoscopists fa-
voring step wise attempts at biliary access starting with the
trans-intrahepatic approach [15]. However, our standard ap-
proach to EUS-guided biliary access during the study period was
EUSr, specifically utilizing the transduodenal approach with the
echoendoscope seated in the duodenal bulb. This decision was
based primarily on the concern for occurrence of bile leak, perito-
nitis and bleeding associated with creation of a fistula between
the lumen of the gastrointestinal tract and the biliary tree when
the antegrade approach is used or transluminal stenting is per-
formed [6]. While these complications are relatively uncommon,
there consequences can be devastating; particularly in the 20% of
patients with potentially resectable pancreaticobiliary tumors.
With the recent introduction of lumen opposing stents, EUS-
guided choledochoduodenosotmy has become an attractive al-
ternative to EUS-guided biliary decompression.[16] However,
the currently available lumen opposing stents were not designed
specifically for the biliary tree andmay pose a risk of cholecystitis
in patients with a gallbladder in situ as well as stent erosion or
migration. Thus, we feel that if EUS guided biliary drainage is at-
tempted rendezvous should remain the preferred first line ap-
proach, given the fact that it preserves the anatomic integrity of
the biliary tree and avoid creation of a fistula.
It remains unclear whether EUS techniques are superior in effica-
cy, safety, and cost when compared to PBD in patients with
MDBO who have failed ERC It is well known that PBD is highly
successful but generally requires repeat procedures and peripro-
cedural adverse events are not infrequent rates ranging from 10%
to 32% in the modern literature [6]. In a recent study, Khashab et
al studied a group of 73 patients with MDBO who failed repeat
ERCP and found that technical success was higher in the PBD
group but the adverse event rate was higher in the latter group
of patients. Regarding successful biliary drainage, defined as re-
duction in total bilirubin by 50% in 2 weeks, the groups were
not statistically different [2]. However, a major critique of the
study is patients were enrolled to the PBD group only after failed
ERCP and EUS-BD; potentially biasing the study against PBD.
In our study AE rates were similar between the EUSr and PBD
groups. However, recurrent biliary obstruction occurred more
frequently and repeated procedures were required more often
in the PBD grou Repeated biliary manipulation may lead to fur-
ther complications and requires the patient to have repeated hos-
pital visits for catheter checks and changes. Recurrent biliary ob-
struction is a major source of morbidity and treatment interrup-
tion in patients undergoing chemotherapy. Given the fact that
EUSr is associated with a lower rate of recurrent biliary obstruc-
tion it stands to reason that this approach would be preferable in
patients receiving neoadjunct or palliative chemotherapy [17,
18]. Moreover, the length of hospital stay was significantly short-
er in the EUSr group, landing another advantage to EUSr; particu-
larly in cases where the initial ERCP is performed on an out-
patient basis and if EUSr is performed in the same endoscopic
session. Finally, we hypothesize that patients would experience
a lower quality of life following PBD when compared to EUSr as
external drainage catheters typically repeated interventions.
It cannot be understated however, that there are important ad-
vantages of PBD. First, PBD is more widely available and the tech-
niques of PBD are well established and standardized. Further-
more, complications of PBD are typically minor and do not re-
quire surgical backup that may only be available at tertiary med-
ical centers. That being said, EUS techniques have a key advantage
of being performed at the same session of ERC However, if initial
EUSr fails, it could be argued that PBD is a safer therapeutic op-
tion given no need for repeat anesthesia and its almost universal
technical success. Technology, ie stents and guidewires, that fo-
cus solely on EUS-BD are needed and currently in development
[19,20]. With the development of technology and as experience
by interventional endoscopists is gained, the technical success
rates of EUS-BD are likely to improve.
The major limitation of our study is its retrospective nature and
limitations inherent to this design. The use of historical controls
may have introduced some degree of bias; however there were
no significant differences in the baseline characteristics and the
protocol (minimum of 23 hours inpatient observation) following
PBD placement remains the same at our institution. We also de-
Table 4 Adverse events.
Adverse events EUSr PBD
Early (< 7 days) 4 3 0.68
Biliary obstruction 0 2
Bleeding 2 1
Pancreatitis 1 0
Bile leak 1 0
Late (> 7 days) 3 6 0.27
Biliary obstruction 2 5
Cholecystitis 1 1




















Fig.2 Kaplan Meyer Estimate of time to biliary obstruction.
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tected no difference in the rate of adverse events comparing EUSr
and PBD, however our sample size may be insufficient to detect a
meaningful difference in this regard. Additionally, this was a sin-
gle-center study; results may not be applicable to institutions
with different practice patterns for endoscopic and percutaneous
biliary drainage. Finally, we focused our study on patients with
malignant distal biliary obstruction and we cannot comment on
the efficacy and safety of EUS guided biliary drainage in the treat-
ment of hilar biliary structures or benign biliary disease.
Conclusions
!
In summary, EUSr is a safe and effective method of biliary drain-
age in patients with MDBO after failed ERC Initial technical suc-
cess with EUSr was significantly lower than with PBD, however
when EUSr was successful patients had a significantly shorter
post-procedure hospital stay and required fewer follow-up bili-
ary interventions than those undergoing PBD.
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